About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Effect of Sevelamer on P-cresol Levels in CKD

NCT02199444·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

eleonora riccio, md
CONTACT
3396770124 [email protected]

Lead

Federico II University

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

age \>18 years,
CKD stage 3-5

You may not be if

Existing or previous treatment within the last 1 year with a phosphate binder;
hyperphosphatemia (\>5.6 mg/dL);
hypophosphatemia (\<2.5 mg/dL);
malnutrition,
malignant neoplasms,
current history of gastrointestinal and/or endocrine diseases.

The record

StatusUnknown

PhasePhase 3

Taking part200

StartedJun 2014

UpdatedFeb 18, 2015

Conditions

Chronic Kidney Disease Stage 3-5

Where1

federico II university, department of nephrology
Naples, Italy, Italy

Clareo Health | Effect of Sevelamer on P-cresol Levels in CKD